标题：The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR(L) in human lung cancer cells
作者：Li, Mingyue; An, Wentao; Xu, Linyan; Lin, Yidan; Su, Ling; Liu, Xiangguo
作者机构：[Li, Mingyue; An, Wentao; Xu, Linyan; Su, Ling; Liu, Xiangguo] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cell & Dev Biol, Room N8-108,72 更多
通讯作者：Su, L;Liu, XG
通讯作者地址：[Su, L; Liu, XG]Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cell & Dev Biol, Room N8-108,72 Binhai Rd, Qingdao 266237, Peoples R China.
来源：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
关键词：CFLAR; PRMT1; PRMT5; ITCH; Apoptosis
摘要：BackgroundCFLAR(L), also known as c-FLIPL, is a critical anti-apoptotic protein that inhibits activation of caspase 8 in mammalian cells. Previous studies have shown that arginine 122 of CFLAR(L) can be mono-methylated. However, the precise role of arginine methyltransferase of CFLAR(L) remains unknown. PRMT5 and PRMT1, which are important members of the PRMT family, catalyze the transfer of methyl groups to the arginine of substrate proteins. PRMT5 can monomethylate or symmetrically dimethylate arginine residues, while PRMT1 can monomethylate or asymmetrically dimethylate arginine residues.MethodsLung cancer cells were cultured following the standard protocol and the cell lysates were prepared to detect the given proteins by Western Blot analysis, and the protein interaction was assayed by co-immunoprecipitation (Co-IP) or GST pull-down assay. CFLAR(L) ubiquitination level was evaluated by proteasomal inhibitor treatment combined with HA-Ub transfection and WB assay. PRMT1 and PRMT5 genes were knocked down by siRNA technique.ResultsWe show that PRMT5 up-regulated the protein levels of CFLAR(L) by decreasing the ubiquitination and increasing its protein level. Additionally, PRMT1 down-regulated the protein level of CFLAR(L) by increasing the ubiquitination and degradation. The overexpression of PRMT5 can inhibit the interaction between CFLAR(L) and ITCH, which has been identified as an E3 ubiquitin ligase of CFLAR(L), while overexpressed PRMT1 enhances the interaction between CFLAR(L) and ITCH. Furthermore, we verified that dead mutations of PRMT5 or PRMT1 have the same effects on CFLAR(L) as the wild-type ones have, suggesting it is the physical interaction between CFLAR and PRMT1/5 that regulates CFLAR(L) degradation other than its enzymatic activity. Finally, we showed that PRMT5 and PRMT1 could suppress or facilitate apoptosis induced by doxorubicin or pemetrexed by affecting CFLAR(L) in NSCLC cells.ConclusionsPRMT5 and PRMT1 mediate the distinct effects on CFLAR(L) degradation by regulating the binding of E3 ligase ITCH in NSCLC cells. This study identifies a cell death mechanism that is fine-tuned by PRMT1/5 that modulate CFLAR(L) degradation in human NSCLC cells.